U.K. Atrial Fibrillation Devices Market
'[ 170 + Pages Research Report ] U.K. Atrial Fibrillation Devices Market tsurpass USD 2.063.9 million by 2031 from USD 706.1 million in 2021 at a CAGR of 11.3% in the coming years, i.e., 2021-2031.
Product Overview
Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with nsymptoms but the most common ones associated with it are palpitations, fainting, congestive chest pain or failure of the heart. The confirmation for AF is obtained by an electrocardiogram which exhibits an absence of the P wave and irregular rate of ventricular contractions. These irregularities in the regular cardio-electric impulses of the sino-atrial node are the result of interference from chaotic electric impulses generating from roots of pulmonary veins consequently leading tthe conduction of an irregular heartbeat.
Market Highlights
U.K. Atrial Fibrillation Devices Market is expected tproject a notable CAGR of 11.3% in 2031.
In U.K. many companies have increased their investment towards research and development in order tinnovate the existing AF devices and tintegrate AI enabled solutions. R&D in atrial fibrillation is expected toffer lucrative growth opportunities for players in the U.K. atrial fibrillation market.
U.K. Atrial Fibrillation Devices Market: Segments
Therapeutic and Surgical Devices segment tgrow with the highest CAGR during 2021-31
Based on Device Type, U.K. Atrial Fibrillation Devices Market is fragmented intDiagnostic and Monitoring Devices and Therapeutic and Surgical Devices. Therapeutic and Surgical Devices segment dominates the market attributed tgrowing demands for ablation catheters for treating AF. This segment is alsexpected twitness highest growth during the forecast period. Among the therapeutic and surgical devices, the Cardiac Rhythm Management Devices segment is the fastest growing segment attributed tincreasing focus towards early diagnosis.
Persistent Atrial Fibrillation segment tgrow with the highest CAGR during 2021-31
The U.K. Atrial Fibrillation Devices Market is classified on the basis of by Disorder Type intParoxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Permanent Atrial Fibrillation, Others Atrial Fibrillation. Persistent Atrial Fibrillation segment accounted for the largest market share of the U.K. Atrial Fibrillation Devices market.
Market Dynamics
Drivers
Growing Adoption Of Closure Devices
Rising number of patients suffering from atrial fibrillation (AF) in the U.K. is the major factors expected tpropel the growth of the market. In addition, the rising cases are alsin resulting in increasing demand for left atrial appendage (LAA) closure devices ttreat patient. The governments are taking initiatives tcreate awareness amongst people regarding the importance of left atrial appendage closure devices during the pandemic, which is the major factor expected tboost the market growth in 2020.
Increase In Prevalence Of Atrial Fibrillation In Geriatric Population
Increasing geriatric population with complication in heart is the major factor driving the market. According tthe Centers for Disease Control and Prevention (CDC), approximately 2 percent of people younger than 65 years old have AFib, while about 9 percent of people ages 65 and older have it.
Restraint
High Cost of U.K. Atrial Fibrillation Devices
High price factor will continue thinder the atrial fibrillation devices market value during the forecast timeframe and impeding the adoption rates in under-developed and few developing countries.
U.K. Atrial Fibrillation Devices Market:
Key Players
Abbott
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Boston Scientific Corporation,
Biotronik,
Cardinal Health,
GE Healthcare,
Medtronic Plc,
Siemens Healthineers AG,
W. L. Gore & Associates, Inc.,
Hansen Medical Inc,
Cardiofocus Inc
Other Prominent Players
U.K. Atrial Fibrillation Devices Market: Regions
U.K. Atrial Fibrillation Devices market is segmented based on regional analysis intfour major regions: England, Northern Ireland, Scotland, and Wales. England is among the top revenue generator for the atrial fibrillation devices. High incidence rate of cardiovascular diseases in the region and development of the strong technologies in the country has witnessed significant growth for the product. The country alshas strong number of players present in the country across the atrial fibrillation value chain Another key country in the region is Northern Ireland, Scotland, Wales. Focus on the improved treatment producers with implementation of the AI in Atrial fibrillations, support the product growth.
Impact of Covid-19 on U.K. Atrial Fibrillation Devices Market
The market of AF devices is expected twitness a healthy growth in 2022 post COVID-19 outbreak. This can be attributed tincreasing awareness among the people about importance of AF devices. This factor will boost the market growth in the forecast years. The rising number of patients suffering from atrial fibrillation (AF) and the growing geriatric population are the major factors expected tpropel the growth of the market. In addition, the rising cases of COVID-19 is resulting in increasing demand for left atrial appendage (LAA) closure devices for treating the patients This is helping the market twitness a progressive growth in the pandemic crisis.
U.K. Atrial Fibrillation Devices Market is further segmented by region into:
England Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Northern Ireland Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Scotland Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Wales Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
U.K. Atrial Fibrillation Devices Market report alscontains analysis on:
U.K. Atrial Fibrillation Devices Market Segments:
By Device Type
Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices
By Disorder Type
Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Permanent Atrial Fibrillation
Others Atrial Fibrillation
By End User
Hospitals
Cardiac Labs
Ambulatory Surgical Centers
Others
U.K. Atrial Fibrillation Devices Market Dynamics
U.K. Atrial Fibrillation Devices Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
Product Overview
Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with nsymptoms but the most common ones associated with it are palpitations, fainting, congestive chest pain or failure of the heart. The confirmation for AF is obtained by an electrocardiogram which exhibits an absence of the P wave and irregular rate of ventricular contractions. These irregularities in the regular cardio-electric impulses of the sino-atrial node are the result of interference from chaotic electric impulses generating from roots of pulmonary veins consequently leading tthe conduction of an irregular heartbeat.
Market Highlights
U.K. Atrial Fibrillation Devices Market is expected tproject a notable CAGR of 11.3% in 2031.
In U.K. many companies have increased their investment towards research and development in order tinnovate the existing AF devices and tintegrate AI enabled solutions. R&D in atrial fibrillation is expected toffer lucrative growth opportunities for players in the U.K. atrial fibrillation market.
U.K. Atrial Fibrillation Devices Market: Segments
Therapeutic and Surgical Devices segment tgrow with the highest CAGR during 2021-31
Based on Device Type, U.K. Atrial Fibrillation Devices Market is fragmented intDiagnostic and Monitoring Devices and Therapeutic and Surgical Devices. Therapeutic and Surgical Devices segment dominates the market attributed tgrowing demands for ablation catheters for treating AF. This segment is alsexpected twitness highest growth during the forecast period. Among the therapeutic and surgical devices, the Cardiac Rhythm Management Devices segment is the fastest growing segment attributed tincreasing focus towards early diagnosis.
Persistent Atrial Fibrillation segment tgrow with the highest CAGR during 2021-31
The U.K. Atrial Fibrillation Devices Market is classified on the basis of by Disorder Type intParoxysmal Atrial Fibrillation, Persistent Atrial Fibrillation, Permanent Atrial Fibrillation, Others Atrial Fibrillation. Persistent Atrial Fibrillation segment accounted for the largest market share of the U.K. Atrial Fibrillation Devices market.
Market Dynamics
Drivers
Growing Adoption Of Closure Devices
Rising number of patients suffering from atrial fibrillation (AF) in the U.K. is the major factors expected tpropel the growth of the market. In addition, the rising cases are alsin resulting in increasing demand for left atrial appendage (LAA) closure devices ttreat patient. The governments are taking initiatives tcreate awareness amongst people regarding the importance of left atrial appendage closure devices during the pandemic, which is the major factor expected tboost the market growth in 2020.
Increase In Prevalence Of Atrial Fibrillation In Geriatric Population
Increasing geriatric population with complication in heart is the major factor driving the market. According tthe Centers for Disease Control and Prevention (CDC), approximately 2 percent of people younger than 65 years old have AFib, while about 9 percent of people ages 65 and older have it.
Restraint
High Cost of U.K. Atrial Fibrillation Devices
High price factor will continue thinder the atrial fibrillation devices market value during the forecast timeframe and impeding the adoption rates in under-developed and few developing countries.
U.K. Atrial Fibrillation Devices Market:
Key Players
Abbott
Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Boston Scientific Corporation,
Biotronik,
Cardinal Health,
GE Healthcare,
Medtronic Plc,
Siemens Healthineers AG,
W. L. Gore & Associates, Inc.,
Hansen Medical Inc,
Cardiofocus Inc
Other Prominent Players
U.K. Atrial Fibrillation Devices Market: Regions
U.K. Atrial Fibrillation Devices market is segmented based on regional analysis intfour major regions: England, Northern Ireland, Scotland, and Wales. England is among the top revenue generator for the atrial fibrillation devices. High incidence rate of cardiovascular diseases in the region and development of the strong technologies in the country has witnessed significant growth for the product. The country alshas strong number of players present in the country across the atrial fibrillation value chain Another key country in the region is Northern Ireland, Scotland, Wales. Focus on the improved treatment producers with implementation of the AI in Atrial fibrillations, support the product growth.
Impact of Covid-19 on U.K. Atrial Fibrillation Devices Market
The market of AF devices is expected twitness a healthy growth in 2022 post COVID-19 outbreak. This can be attributed tincreasing awareness among the people about importance of AF devices. This factor will boost the market growth in the forecast years. The rising number of patients suffering from atrial fibrillation (AF) and the growing geriatric population are the major factors expected tpropel the growth of the market. In addition, the rising cases of COVID-19 is resulting in increasing demand for left atrial appendage (LAA) closure devices for treating the patients This is helping the market twitness a progressive growth in the pandemic crisis.
U.K. Atrial Fibrillation Devices Market is further segmented by region into:
England Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Northern Ireland Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Scotland Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
Wales Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR
U.K. Atrial Fibrillation Devices Market report alscontains analysis on:
U.K. Atrial Fibrillation Devices Market Segments:
By Device Type
Diagnostic and Monitoring Devices
Therapeutic and Surgical Devices
By Disorder Type
Paroxysmal Atrial Fibrillation
Persistent Atrial Fibrillation
Permanent Atrial Fibrillation
Others Atrial Fibrillation
By End User
Hospitals
Cardiac Labs
Ambulatory Surgical Centers
Others
U.K. Atrial Fibrillation Devices Market Dynamics
U.K. Atrial Fibrillation Devices Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints
1. EXECUTIVE SUMMARY
2. U.K. ATRIAL FIBRILLATION DEVICES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. U.K. ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. U.K. ATRIAL FIBRILLATION DEVICES MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. U.K. ATRIAL FIBRILLATION DEVICES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. England, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Northern Ireland, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Scotland, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Wales, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Device Type: Market Share (2020-2031F)
12.2.1. Diagnostic and Monitoring Devices, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Therapeutic and Surgical Devices, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Disorder Type: Market Share (2020-2031F)
12.3.1. Paroxysmal Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Persistent Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Permanent Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.4. Others Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End-User: Market Share (2020-2031F)
12.4.1. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Cardiac Labs, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Ambulatory Surgical Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. COMPANY PROFILE
13.1. Abbott,
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Boston Scientific Corporation,
13.3. Biotronik,
13.4. Cardinal Health,
13.5. GEHealthcare,
13.6. Medtronic Plc,
13.7. Siemens Healthineers AG,
13.8. W. L. Gore & Associates, Inc.,
13.9. Hansen Medical Inc,
13.10. Cardio focus.
13.11. Other Prominent Players
14. CONSULTANT RECOMMENDATION
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
2. U.K. ATRIAL FIBRILLATION DEVICES MARKET
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. RESEARCH METHODOLOGY
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. AVERAGE PRICING ANALYSIS
5. MACRO-ECONOMIC INDICATORS
6. MARKET DYNAMICS
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. CORRELATION & REGRESSION ANALYSIS
7.1. Correlation Matrix
7.2. Regression Matrix
8. RECENT DEVELOPMENT, POLICIES & REGULATORY LANDSCAPE
9. RISK ANALYSIS
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. U.K. ATRIAL FIBRILLATION DEVICES MARKET ANALYSIS
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. U.K. ATRIAL FIBRILLATION DEVICES MARKET
11.1. Market Size & forecast, 2020A-2031F
11.1.1. By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
11.1.2. By Volume (Million Units) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12. U.K. ATRIAL FIBRILLATION DEVICES MARKET: MARKET SEGMENTATION
12.1. By Regions
12.1.1. England, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.2. Northern Ireland, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.3. Scotland, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.1.4. Wales, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2. By Device Type: Market Share (2020-2031F)
12.2.1. Diagnostic and Monitoring Devices, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.2.2. Therapeutic and Surgical Devices, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3. By Disorder Type: Market Share (2020-2031F)
12.3.1. Paroxysmal Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.2. Persistent Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.3. Permanent Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.3.4. Others Atrial Fibrillation, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4. By End-User: Market Share (2020-2031F)
12.4.1. Hospitals, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.2. Cardiac Labs, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.3. Ambulatory Surgical Centers, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
12.4.4. Others, By Value (USD Million) 2020-2031F; Y-o-Y Growth (%) 2021-2031F
13. COMPANY PROFILE
13.1. Abbott,
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Boston Scientific Corporation,
13.3. Biotronik,
13.4. Cardinal Health,
13.5. GEHealthcare,
13.6. Medtronic Plc,
13.7. Siemens Healthineers AG,
13.8. W. L. Gore & Associates, Inc.,
13.9. Hansen Medical Inc,
13.10. Cardio focus.
13.11. Other Prominent Players
14. CONSULTANT RECOMMENDATION
The above given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.
